XKRX
025620
Market cap75mUSD
Oct 08, Last price
5,550.00KRW
1D
1.28%
1Q
-21.39%
Jan 2017
-11.90%
Name
Jayjun Cosmetic Co Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Based in Incheon, South Korea, CHA AI Healthkare Co., Ltd. is a cosmetics company that produces and distributes a wide array of beauty products. Established on June 30, 1972, its offerings encompass various skincare and makeup essentials, including serums, creams, toners, moisturizers, emulsions, masks, BB creams, and cushions.
Key people
Chief Executive Officer, Director · since 2023
Jong Han Shin
Vice President · since 2023
Yil Geun Yang
Internal Auditor · since 2022
Gyeong Jae Jeon
Chief Executive Officer, Director · since 2025
Hyo Beom Jin
Director · since 2025
Yin Cheol Jung
Director · since 2025
Jeong Seon Kim
Director · since 2023
Seong Jun Kim
Director · since 2022
Yeong Lee
Director · since 2025
Jeong Wan Oh
Director · since 2022
Sang Hun Son
Director · since 2025
Seong Hui Won
Director · since 2022
Jae Won Yang
Director · since 2023
Jin Pyeong Yoo
Director · since 2025
Wun Cheol Baek
Non-Executive Independent Director · since 2025
Mun Ju Kim
Non-Executive Independent Director · since 2022
Na Yun Park
Non-Executive Independent Director · since 2025
Seung Ha Yoo
Non-Executive Independent Director · since 2022
Valuation
Title KRW in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||